Celldex Therapeutics (CLDX) Long-Term Debt Issuances (2010 - 2013)

Celldex Therapeutics' Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at $428000.0 for Q4 2013.

• On a quarterly basis, Long-Term Debt Issuances rose 2957.14% year-over-year to $428000.0 in Q4 2013; TTM through Dec 2020 was $443000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $3.0 million, changed N/A from the prior year.
• Long-Term Debt Issuances improved to $428000.0 in Q4 2013 per CLDX's latest filing, from $15000.0 in the prior quarter.
• Across five years, Long-Term Debt Issuances topped out at $4.9 million in Q3 2011 and bottomed at -$1.3 million in Q2 2012.
• The 4-year median for Long-Term Debt Issuances is $15000.0 (2012), against an average of $433076.9.
• Across the five-year window, Long-Term Debt Issuances surged 9590.2% in 2011 and slumped 11250.0% in 2012, its largest moves.
• Year by year, Long-Term Debt Issuances stood at $52000.0 in 2010, then surged by 9403.85% to $4.9 million in 2011, then plunged by 99.72% to $14000.0 in 2012, then jumped by 2957.14% to $428000.0 in 2013.
• Per Business Quant, the three latest CLDX Long-Term Debt Issuances figures stand at $428000.0 (Q4 2013), $15000.0 (Q3 2013), and $14000.0 (Q2 2013).